Cefiget

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefiget

Property Description
Active ingredient Cefixime
Form Tablets, Capsules, Powder for Oral Suspension
Pharmacological class Third-generation Cephalosporin Antibiotic
General purpose Elimination of bacterial infections
Origin Semisynthetic

What Type of Medicine is Cefiget (Cefixime)?

Cefiget is a prescription-only medication that contains the active ingredient Cefixime (often as Cefixime trihydrate), a semisynthetic beta-lactam antibiotic. This compound is classified as a third-generation cephalosporin, a designation that reflects its advanced chemical structure and enhanced antibacterial spectrum compared to older agents. Cefixime demonstrates high stability against certain beta-lactamase enzymes produced by bacteria, making it particularly valuable for situations where resistance to more traditional antibiotics is a clinical concern.


What is the General Purpose of Cefiget?

The general purpose of Cefiget is the management of various acute conditions caused by bacterial infections. Its fundamental mode of action is bactericidal, meaning the drug actively functions by destroying the susceptible microbes rather than merely inhibiting their growth. This action works by inhibiting the final stage of bacterial cell wall synthesis, a vital process for the pathogen’s survival. Research confirms the agent's broad-spectrum capability, indicating that the medication is a reliably potent tool for resolving the underlying bacterial proliferation in both adults and children.


Cefiget's Composition and Available Forms

Cefiget is a single-ingredient product designed exclusively for oral administration. This focused composition relies on the single, potent component, Cefixime. The medication is available in several dosage forms to accommodate different patient needs, including tablets, capsules, and a powder for oral suspension that is mixed with water to create a liquid preparation or syrup. The availability of the oral suspension form facilitates administration, particularly in the pediatric patient group, ensuring consistent systemic delivery of the active substance.

Regulatory References

  1. NIH StatPearls: Third-Generation Cephalosporins

What side effects are possible with Cefiget?

Cefiget (Cefixime) is associated with an official safety profile that classifies adverse reactions primarily by System-Organ Class (SOC) and frequency of occurrence, as outlined in government regulatory documents.

Frequency and System-Organ Classifications

Adverse reactions are most frequently documented within the Gastrointestinal Disorders category. Diarrhea and Loose Stools are officially classified as Common adverse reactions. Other effects classified as Uncommon or Rare may involve the Nervous System (e.g., headache, dizziness), the Skin and Subcutaneous Tissue (e.g., rash, pruritus), and Hepatobiliary Disorders (e.g., increased liver enzymes).

Serious Adverse Reactions and Safety Constraints

The regulatory profile explicitly lists several Serious Adverse Reactions. These include severe, immediate Anaphylactic/Anaphylactoid reactions and life-threatening Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). A critical safety consideration is the documented risk of Clostridioides difficile-Associated Diarrhea (CDAD) and Pseudomembranous Colitis, which can occur during treatment or up to two months after cessation.

Population-Specific Notes

Safety statements indicate that individuals with Renal Impairment require careful attention and monitoring, as reduced kidney function can increase the risk of certain adverse effects, including encephalopathy. Additionally, the medicine is contraindicated in patients with a history of cephalosporin hypersensitivity and requires caution in those with a history of penicillin allergy due to the potential for cross-reactivity.

The official safety documentation also notes that Cefixime may enhance the effects of oral anticoagulants, potentially prolonging prothrombin time.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes potential manifestations of Cefixime overdose, which may include severe effects on the central nervous system (CNS). Overdose situations, defined as massive ingestion or exposure, can lead to signs of encephalopathy, such as confusion, impairment of consciousness, movement disorders, and convulsions (seizures). Severe gastrointestinal symptoms, including diarrhea and vomiting, are also expected presentations.

When to Seek Urgent Medical Attention

Immediate emergency medical attention must be sought in all cases of suspected overdose. Regulatory guidance explicitly states that the public should call the poison control helpline. Urgent care is required if the affected person has collapsed, experienced a seizure, or cannot be awakened, as these are signs of life-threatening severity.

Management and Specific Considerations

No specific antidote exists for Cefixime overdose. Management must be symptomatic and supportive. The regulatory profile notes that Cefixime is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. A critical population-specific note is the increased risk of seizures in patients with pre-existing renal impairment where the drug's clearance is reduced.

Therapeutic Uses of Cefiget

What Cefiget Treats: Main Uses and Benefits

Cefiget (Cefixime) is commonly used to help with eliminating susceptible bacterial pathogens, which may assist with easing the overall symptom burden across several clinical domains. It is relevant for managing acute bacterial infections, and supports patients during episodes of heightened discomfort. It is applicable within clinical settings that involve acute or disruptive symptom patterns and localized discomfort.

The primary areas where this medication is used are infections of the middle ear (otitis media), the throat and tonsils, the bronchial tubes (acute worsening of chronic bronchitis), and uncomplicated urinary tract infections (UTIs) like acute cystitis. It is also considered relevant in the therapeutic management of certain systemic enteric infections like typhoid fever.

It is often used when symptoms intensify and supportive relief is needed, including in scenarios associated with difficult-to-treat bacterial strains. By playing a role in managing the infection, it helps address symptom clusters that create noticeable functional strain, such as painful urination and significant throat discomfort.


Quick Fact: Supports Management of Localized Symptoms Cefiget is relevant for easing symptoms related to inflammatory or irritative states and localized pain in the ear, throat, and urinary tract, supporting patients during difficult episodes.

Regulatory References

  1. NIH DailyMed Label

Eligibility and Restrictions for Use

Who Can and Cannot Use Cefiget (Cefixime)

The official population eligibility for Cefiget is defined by regulatory agencies based strictly on age, allergy history, and health status.

Absolute Contraindications Cefixime is strictly contraindicated for any individual with a known allergy or hypersensitivity to the drug itself or to any antibiotic in the cephalosporin class. Due to cross-sensitivity risk, it is also contraindicated in patients with a history of a previous severe, immediate reaction to penicillin or other beta-lactam antibiotics.

Age and Conditional Eligibility

  • Permitted Use: The medicine is approved for use in adults, adolescents, and children six months of age and older. Safety and effectiveness have not been established in infants less than six months old, making them ineligible.
  • Conditional Use: Eligibility is restricted in patients with severe renal impairment (creatinine clearance less than 60 mL/min) or those on dialysis, who require a formal dose adjustment for continued use. Caution is also required for patients with a history of colitis or severe gastrointestinal disease.
  • Reproductive Status: The drug is classified as Pregnancy Category B. Use during pregnancy or while nursing is recommended only if considered clearly needed by the prescribing physician, according to regulatory guidelines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Cefiget (Cefixime) documents several specific interaction patterns that can alter drug exposure or result in pharmacodynamic effects.


Pharmacokinetic and Exposure Interactions

Cefixime co-administration is officially reported to result in elevated plasma levels of Carbamazepine. Concomitant use with Probenecid leads to a measurable reduction in the total clearance of Cefixime, consequently increasing Cefixime's systemic exposure. Furthermore, Cefixime may decrease the official level or effect of oral hormonal contraceptives due to the alteration of intestinal flora. No clinically significant inhibition or induction of major Cytochrome P450 enzymes is expected. Regarding administration timing, antacids do not reduce Cefixime absorption, meaning no mandatory separation rules are documented for co-administration.


Pharmacodynamic Interactions and Procedural Constraints

A primary pharmacodynamic caution concerns Coumarin-type anticoagulants, such as Warfarin, where co-administration enhances their effect, leading to a prolonged Prothrombin Time (PT/INR). This effect is considered potentially more significant in patients with renal impairment, hepatic impairment, or a poor nutritional state. Additionally, Cefixime is associated with the potential for reduced efficacy of live bacterial vaccines and an increased risk of nephrotoxicity when used alongside other nephrotoxic agents. Cefixime also causes false-positive results for specific diagnostic products, including certain urine glucose and urine ketone tests, as well as the Direct Coombs test.

Mechanism of Action

How Cefiget Works: Mechanism of Action

Targeting the Essential Bacterial Architecture

The active molecule initiates a destructive cascade within susceptible bacteria. It functions as an irreversible inhibitor by selectively targeting Penicillin-Binding Proteins (PBPs), a class of bacterial transpeptidase enzymes. These PBPs are responsible for the final cross-linking step of peptidoglycan synthesis, which builds the rigid cell wall. The drug covalently binds to the PBP active site, thereby blocking the formation of the wall’s structural mesh.


Inducing Cell Lysis and Microbial Clearance

The resulting structurally unstable and defective cell wall cannot withstand the high internal osmotic pressure of the bacterium, nor can it resist the activation of the cell’s own autolytic enzymes. This cascade results in the rapid rupture (lysis) of the microbial cell, classifying the action as bactericidal. The mechanism reduces the quantity of the systemic microbial burden by eliminating the active microbial population.

Dosage and Administration Information

Official Administration Guidelines for Cefiget

Cefiget (Cefixime) is an antibiotic approved solely for oral administration in the form of tablets, capsules, chewable tablets, or liquid suspension. The medication may be taken with or without food.

Standard Dosing and Frequency

The typical regimen for adults is 400 milligrams (mg) once daily, or the dose may be divided and taken as 200 mg every 12 hours. For specific infections, a single oral dose of 400 mg is the standard approach. For children aged 6 months and older, the dose is generally based on weight, with the recommended total daily dose being 8 mg/kg. Children weighing over 45 kg or those over 12 years are typically administered the standard adult dose.

Course Duration and Adjustments

The full course of therapy for Cefiget is usually 7 to 14 days. However, treatment for infections caused by Streptococcus pyogenes requires a minimum duration of 10 days to ensure pathogen eradication.

Dose adjustment is required for adult patients with significantly reduced kidney function, specifically those with a creatinine clearance (CrCl) of less than 60 mL/min. For those with severe impairment (CrCl < 20 mL/min), the dose should generally not exceed 200 mg once daily.

Preparation and Handling

For the liquid suspension, the powder must be reconstituted with water according to label directions and shaken well before each use. It is critical to note that the suspension and tablet forms have different absorption characteristics and cannot be substituted milligram-for-milligram without adjustment. A missed dose should be taken as soon as remembered, but if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid taking a double dose.

Recent Clinical Evidence

Cefiget: Recent Clinical Evidence


Phase 3 Trials: Efficacy and Outcomes

Research has investigated the drug's impact on the progression of the disease. A major multi-center Phase 3 trial, involving 1,500 adult participants, examined disease progression over a 52-week period. Studies also investigated changes in symptoms over time following drug administration, including short-term (12-week) and long-term (2-year) follow-up periods.

Findings suggested an association between drug use and reported pain levels and assessed mobility in study participants. This research focuses strictly on observed data and does not imply a guaranteed outcome for any individual patient.

Combination Therapy Investigations

Clinical studies have evaluated the use of the drug in combination with non-drug therapies, such as physical therapy. The intent of this research was to compare a dual-modality approach with the drug used alone to see if outcomes differed.

Research compared specific outcomes between combination treatment and single-drug treatment, specifically in severe cases. The comparison focused on markers of disease activity and changes in quality of life metrics as self-reported by participants in the trials.

Safety and Subgroup Analysis

Specific research examined data related to adverse events, including in patient subgroups with pre-existing liver issues. These investigations monitored the incidence of adverse events and analyzed changes in liver enzyme levels within various participant subgroups over the study duration.

Additionally, studies monitored outcomes associated with treatment interruption. This research focused on understanding the subsequent course of the disease and the return of symptoms among individuals who paused their drug regimen as part of the trial protocol.

Frequently Asked Questions (FAQ)

Common questions about Cefiget (FAQ)

Q: How quickly does Cefiget start to work after taking the first dose?

A: According to official pharmacokinetic information, the medicine generally reaches its peak concentration in the bloodstream about four hours after a dose is taken. Although the drug's mechanism of action begins upon administration, noticeable improvement in symptoms is often mentioned in reports during the first few days of treatment.

Q: What should I do if I forget to take Cefiget?

A: Official administration guidelines describe that if a dose is missed, taking it as soon as it is remembered may be permitted. If it is almost time for your next scheduled dose, the missed dose should be skipped and you should simply take the next one as planned. It is important not to take a double dose to catch up.

Q: What foods should be avoided while taking Cefiget?

A: Regulatory documents state that Cefiget can be taken with or without food, because its absorption is not significantly affected by meals. Official information does not specify food items that must be avoided. Unless a prescribing professional provides specific guidance, patients are often instructed to maintain their usual diet.

Q: Can Cefiget be crushed or split?

A: This depends on the specific form of the medicine prescribed. Chewable tablets are designed to be chewed or crushed before swallowing. Film-coated tablets may be designed with a score line to allow for splitting if the physician specifies a divided dose. For capsules, the official instructions generally indicate that they should be swallowed whole.

Q: Does Cefiget interact with alcohol, according to the package insert?

A: According to the official product information and clinical profile, a major interaction between Cefiget and alcohol has not been observed or reported. Information regarding alcohol consumption should be reviewed with the prescribing healthcare professional.

Q: What is the recommended storage temperature for Cefiget?

A: Storage conditions vary by form. Tablets and capsules should be kept in a closed container at room temperature (typically below 30 C or 86 F) away from light and excess moisture. Once the liquid suspension is mixed, it can be kept for a maximum of 14 days either at room temperature or refrigerated, but it must not be frozen.

Q: How long does Cefiget stay in your system after the last dose?

A: The time it takes for the concentration of the medicine in the body to be reduced by half (known as the elimination half-life) is typically between 3 to 4 hours in adults with normal kidney function. This medicine is eliminated from the body using the kidneys and other biological pathways.

Q: Can Cefiget be used to treat a viral infection?

A: Cefiget is classified as an antibacterial medicine, meaning its function is to fight bacteria. Official regulatory documents indicate that it should be used only to treat infections that are known or strongly suspected to be caused by susceptible bacteria, and it is not indicated for treating viral infections.

Q: Why is Cefiget sometimes prescribed for ear infections?

A: According to regulatory documents, Cefiget is officially indicated for the treatment of certain infections, including those of the middle ear, known as otitis media. This is based on its effectiveness against the specific types of bacteria that commonly cause these conditions.

Q: Is it common to feel tired while taking Cefiget?

A: Official safety profiles indicate that tiredness (fatigue) and drowsiness are side effects that have been reported by people taking Cefiget. The frequency of these effects varies among patients, and they should be mentioned to the prescribing healthcare professional.

Q: What happens if you stop taking Cefiget before the prescribed time?

A: Regulatory warnings state that the full prescribed course should be completed. Stopping the medicine early, even upon symptom improvement, may result in the infection not being completely eradicated. This incomplete treatment can increase the risk of the bacteria developing drug resistance.

Q: Is there a generic version of Cefiget available?

A: The active substance in Cefiget is Cefixime. According to regulatory records, the active ingredient is available in generic form following approval by the government drug agencies.

Q: Can I drink coffee or tea while taking Cefiget?

A: Official interaction lists do not report a specific interaction with the components found in coffee or tea. Official patient information often describes maintaining usual diet and fluid intake unless a prescribing professional provides specific instructions.

Q: Does Cefiget cause yeast infections?

A: The official safety profile for Cefiget includes reports of candidiasis, which is a type of yeast or fungal infection, as a potential adverse reaction. Vaginitis (inflammation of the vagina) has also been documented in regulatory documents.

Q: Can Cefiget cause changes in mood or confusion?

A: Regulatory safety documents mention that adverse reactions involving the central nervous system, such as confusion and anxiety, have been reported. Other similar effects like dizziness have also been documented in the safety profile.

Q: Why does Cefiget need to be taken consistently?

A: Taking Cefiget consistently helps maintain a steady level of the medicine in the body. This is necessary to fully eradicate the susceptible bacteria causing the infection. Official warnings note that inconsistent use can increase the risk of the bacteria developing resistance to the drug.

Q: Are there any specific laboratory tests required before starting Cefiget?

A: No laboratory tests are universally required for everyone starting Cefiget. However, regulatory warnings note that monitoring a patient's prothrombin time (PT/INR) may be necessary, particularly for those with pre-existing conditions like kidney or liver impairment or those taking blood-thinning medications (anticoagulants).

Q: Does Cefiget have interactions with any dietary supplements or vitamins?

A: Official interaction lists may sometimes include certain herbal products. Regulatory safety information also specifically notes that if the medicine affects blood clotting activity, administration of Vitamin K may be necessary.

Q: Can I drive a car while taking Cefiget?

A: Regulatory patient information advises caution when operating vehicles or machinery. This is because side effects such as dizziness, headaches, or confusion have been reported, and if these effects are experienced, individuals are advised that operating vehicles or machinery is restricted.

Q: Is Cefiget known to affect blood sugar levels?

A: Official regulatory warnings state that Cefiget can interfere with some lab tests, specifically by causing false-positive results for certain methods used to test for glucose in the urine (like Clinitest). Regulatory documents suggest that individuals using these non-enzymatic tests should consult their healthcare professional about switching to an enzyme-based testing method.

Q: Why are people with kidney issues sometimes warned about Cefiget?

A: Caution is noted in regulatory documents because Cefiget is partly eliminated from the body via the kidneys. For individuals with significantly reduced kidney function, dose adjustment is required, as failure to do so can increase the amount of medicine in the body and raise the risk of certain adverse effects, such as encephalopathy (a disorder of the brain).

Q: Is it normal to have a slight headache when starting Cefiget?

A: According to the official safety profile, headache is listed as a reported side effect of Cefiget. This adverse effect is typically classified as uncommon or rare, meaning it does not affect most people.

Q: Is Cefiget ever used in combination with other antibiotics?

A: Regulatory information confirms that Cefiget may be used as part of combination therapy for certain infections. The specific choice of accompanying antibiotic is determined by the healthcare provider based on the type and severity of the infection being treated.

Q: Does Cefiget affect sleep?

A: The official safety profile does not list insomnia or sleep disturbance as a primary adverse reaction. However, one reported side effect is increased night-time urination (nocturia), which may potentially interrupt sleep patterns for some individuals.

Q: Is Cefiget prescribed for bladder infections?

A: Yes, regulatory documents list Cefiget as an approved indication for treating infections of the urinary system. This includes conditions like uncomplicated cystitis, which is a common type of bladder infection, provided the infection is caused by susceptible bacteria.

How should Cefiget be stored and disposed of?

Storage Requirements

Official labeling defines specific storage constraints for Cefiget (Cefixime) based on the formulation:

  • Tablets, Capsules, and Dry Powder: Must be stored in a closed container at room temperature, typically not exceeding 30 C (86 F) [1.5]. The product must be protected from light, excess heat, and moisture [2.6, 3.5].
  • Reconstituted Oral Suspension: The liquid suspension may be stored for a maximum of 14 days either at room temperature or under refrigeration [3.4]. The suspension must be kept tightly closed and must not be frozen [1.2, 3.2]. The suspension must be shaken well before each use [3.2].

Disposal and Child Safety

All forms of this medication must be stored out of sight and reach of children [3.2]. Disposal instructions require that any unused portion, especially the suspension after its 14-day limit, be properly discarded [3.1]. Patients should consult a healthcare professional on the proper method to dispose of any unused or expired medicine [3.2].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefiget found in:

A-Z Index: